B. Metzler seel. Sohn & Co’s GSK GSK Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,367	Closed	-$938K	–	773
2024 Q2	$938K	Buy	24,367 +9,857	+68%	+$415K	0.01%	539
2024 Q1	$622K	Hold	14,510	–	–	0.01%	591
2023 Q4	$538K	Buy	14,510 +2,204	+18%	+$79.1K	0.01%	605
2023 Q3	$446K	Hold	12,306	–	–	0.01%	596
2023 Q2	$439K	Sell	12,306 -855	-6%	-$30.7K	0.01%	596
2023 Q1	$468K	Hold	13,161	–	–	0.01%	562
2022 Q4	$462K	Sell	13,161 -1,041	-7%	-$34.7K	0.01%	570
2022 Q3	$418K	Buy	+14,202	New	+$538K	0.01%	572

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

B. Metzler seel. Sohn & Co's GSK Position: Q3 2024 in Review

B. Metzler seel. Sohn & Co sold out of GSK (GSK) in Q3 2024, closing a stake of 24,367 shares — an estimated $938K sold.

B. Metzler seel. Sohn & Co first reported a position in GSK in Q3 2022 and held it in 8 quarters. The position peaked at $938K in Q2 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

B. Metzler seel. Sohn & Co reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
B. Metzler seel. Sohn & Co sold 24,367 GSK shares in Q3 2024, an estimated $938K.
B. Metzler seel. Sohn & Co first reported a position in GSK in Q3 2022 and held it in 8 quarters.
B. Metzler seel. Sohn & Co's GSK position peaked at $938K in Q2 2024.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q3 2024, filed 8 Nov 2024.